
GK Daily Special Edition: The Empty Shelf Problem — How the World's Richest Country Runs Out of Chemo and Amoxicillin
Somewhere this morning, a hospital pharmacist opened a spreadsheet and started deciding which cancer patients get the full dose of a drug that costs less than a fast-food lunch. Not because the drug is experimental, or rare, or expensive. Because there isn't enough of it, in the United States, in 2026.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.